-transparent.png){kind=logo}
At our center, KPT is the treatment of choice for diabetics with ESRD who are not irreversibly disabled by their secondary complications of diabetes. Mortality, as a result of cardiovascular complications, has a significant impact on the outcome of patients in both the KPT and KTA groups. Metabolic complications are problematic in the early posttransplant period. Infectious complications are frequent but not life threatening in the combined recipients. Excellent graft outcome (pancreas and kidney) can be achieved in those patients selected to undergo the KPT procedure.
Related Publications
M L Henry, and
B L Ketel, and
E A Elkhammas, and
R J Tesi, and
R M Ferguson
August 1979,
Lancet (London, England),
M L Henry, and
B L Ketel, and
E A Elkhammas, and
R J Tesi, and
R M Ferguson
September 1987,
Missouri medicine,
M L Henry, and
B L Ketel, and
E A Elkhammas, and
R J Tesi, and
R M Ferguson
March 1973,
Transplantation proceedings,
M L Henry, and
B L Ketel, and
E A Elkhammas, and
R J Tesi, and
R M Ferguson
January 2006,
Clinical transplantation,
M L Henry, and
B L Ketel, and
E A Elkhammas, and
R J Tesi, and
R M Ferguson
April 2015,
Transplantation proceedings,
M L Henry, and
B L Ketel, and
E A Elkhammas, and
R J Tesi, and
R M Ferguson
January 2004,
Prilozi,
M L Henry, and
B L Ketel, and
E A Elkhammas, and
R J Tesi, and
R M Ferguson
June 1984,
Transplantation proceedings,
M L Henry, and
B L Ketel, and
E A Elkhammas, and
R J Tesi, and
R M Ferguson
March 1982,
The New England journal of medicine,
M L Henry, and
B L Ketel, and
E A Elkhammas, and
R J Tesi, and
R M Ferguson
October 1982,
The New England journal of medicine,
M L Henry, and
B L Ketel, and
E A Elkhammas, and
R J Tesi, and
R M Ferguson
February 1985,
Lancet (London, England),
